Statistics for Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial
Total visits
| views | |
|---|---|
| Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial | 2 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 2 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:c3f3d513-fb2e-4167-a1ac-15b62aea509e | 18 |
| java.util.UUID:6d3748ad-5491-4a75-8dd7-e866bb02d2e7 | 13 |
| java.util.UUID:812c973f-9f45-45f1-b54d-d4d7254f694d | 2 |
| Sarraju2021Effects-PP.pdf | 1 |
Top country views
| views | |
|---|---|
| United States | 2 |
Top city views
| views | |
|---|---|
| Franklin | 2 |